Beginner's Guide To Minimal Risk Research
Source: Advarra
By Meghan Hosely, Marketing Copywriter

When an institutional review board (IRB) determines research is “minimal risk” (as defined in Department of Health and Human Services [HHS] and Food and Drug Administration [FDA] regulations), the research is potentially eligible for several regulatory flexibilities. How can researchers know when research is minimal risk? This blog aims to provide a beginner’s overview to the regulatory concept of “minimal risk,” and which regulatory flexibilities research might be eligible for.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Advarra
This website uses cookies to ensure you get the best experience on our website. Learn more